162 related articles for article (PubMed ID: 37709654)
1. Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data.
Bosi A; Barcellini W; Passamonti F; Fattizzo B
Blood Rev; 2023 Nov; 62():101132. PubMed ID: 37709654
[TBL] [Abstract][Full Text] [Related]
2. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
4. Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
Pagliuca S; Kulasekararaj AG; Eikema DJ; Piepenbroek B; Iftikhar R; Satti TM; Griffin M; Laurino M; Kupesiz A; Bertrand Y; Fattizzo B; Yakoub-Agha I; Aljurf M; Corti P; Massaccesi E; Lioure B; Calabuig M; Klammer M; Unal E; Wu D; Chevallier P; Forcade E; Snowden JA; Ozdogu H; Risitano A; De Latour RP
Haematologica; 2024 Mar; 109(3):765-776. PubMed ID: 37199126
[TBL] [Abstract][Full Text] [Related]
5. Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist.
Li J; Bledsoe JR
Semin Diagn Pathol; 2023 Nov; 40(6):429-442. PubMed ID: 37507252
[TBL] [Abstract][Full Text] [Related]
6. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
Malcovati L; de Latour RP; Risitano A
Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
[TBL] [Abstract][Full Text] [Related]
7. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
Visconte V; Lindsley RC; Berlyne D
Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
9. When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis.
Bonadies N; Rovó A; Porret N; Bacher U
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801484
[TBL] [Abstract][Full Text] [Related]
10. Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes.
Piedras J; Hernández G; López-Karpovitch X
Am J Hematol; 1998 Feb; 57(2):113-8. PubMed ID: 9462542
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
13. Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Selleri C; Serio B; Risitano AM
Mini Rev Med Chem; 2011 Jun; 11(6):536-43. PubMed ID: 21561402
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndrome associated with bone marrow fibrosis.
Lambertenghi-Deliliers G; Annaloro C; Oriani A; Soligo D
Leuk Lymphoma; 1992 Sep; 8(1-2):51-5. PubMed ID: 1493471
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and Therapy of aplastic anemia - update 2021].
Panse J
Dtsch Med Wochenschr; 2021 Apr; 146(7):451-454. PubMed ID: 33780990
[TBL] [Abstract][Full Text] [Related]
16. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of aplastic anemia.
Wang L; Liu H
Hematology; 2019 Dec; 24(1):559-566. PubMed ID: 31315542
[TBL] [Abstract][Full Text] [Related]
18. [Exclusive diagnosis of aplastic anemia].
Wang HQ; Shao ZH
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(12):830-832. PubMed ID: 35330574
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
[TBL] [Abstract][Full Text] [Related]
20. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
